NEW YORK, NY, and MONTREAL, Nov. 9 /PRNewswire-FirstCall/ - BioSpec Global Solutions Inc., and partner -ICBS Ltd. (OTCPK: ICBT), announced that Richard Howarth has been appointed Technical Director.

Mr. Howarth received his B.Sc., in Applied Chemistry of Polymers in 1971 from Manchester, Polytechnic in the UK. He is currently the Senior Technologist at Bombardier Aerospace, and has been with Bombardier for the past 28 years.

"Mr. Howarth will be involved in all of the new R&D projects for the advanced TOGS(TM) 9000." Said Don Saunders President and CEO BioSpec Global Solutions. "We are very excited about the addition to our team of someone with Mr. Howarth' s experience."

The development will include the building of hardware and optical system. Software and methodologies for simultaneous detection and enumeration of the microbes in various types of food samples. TOGS 9000 new model will be a method for the enumeration of total Coliforms, E.coli and Enterococci in fresh water, marine water for routine recreational water testing.

The second phase will be the development and site method validation (for FDA approval) of viable microbial count (VMC or total bacterial count) in water for pharmaceutical quality assurance process.

Having the ability to test water efficiently and quickly can provide pharmaceutical companies with the ability to monitor their production systems.

The Pro3000(TM) has been verified by Ryerson University, Agriculture Canada and Saskatchewan Department of Health. It has been accepted for use for drinking water analysis by EPA in the USA when used in conjunction with an EPA approved reagent The TOGS 9000 and 3000 have been used in a research project by the World Health Organization in Hawaii and by OCETA in India.

The company holds worldwide patents on the TOGS 3000 and 9000.

    NB. This news release includes statements that constitute forward-looking
    statements. Please be aware that any such forward-looking statements are
    not guarantees of future performance and involve significant risks and
    uncertainties, and that actual results may vary materially from those in
    the forward-looking statements as a result of any number of factors,
    including the risk factors contained in the Company's disclosure
    documents.

SOURCE Inter Canadian Business Service

Back to top